Shenzhen Chipscreen Biosciences Co Current ratio
What is the Current ratio of Shenzhen Chipscreen Biosciences Co?
The Current ratio of Shenzhen Chipscreen Biosciences Co., Ltd. is 2.84
What is the definition of Current ratio?
Current ratio is a liquidity ratio that measures whether or not a company has enough resources to meet its short-term obligations.
mrq (most recent quarter)
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
Current ratio of companies in the Health Care sector on SSE compared to Shenzhen Chipscreen Biosciences Co
What does Shenzhen Chipscreen Biosciences Co do?
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.
Companies with current ratio similar to Shenzhen Chipscreen Biosciences Co
- Daura Capital has Current ratio of 2.84
- Herald has Current ratio of 2.84
- Pro-Dex (co) has Current ratio of 2.84
- Blue Capital Reinsurance Ltd has Current ratio of 2.84
- Blue Capital Reinsurance has Current ratio of 2.84
- Major Drilling International has Current ratio of 2.84
- Shenzhen Chipscreen Biosciences Co has Current ratio of 2.84
- Straumann AG has Current ratio of 2.84
- Grupo Rotoplas S.A.B. de C.V has Current ratio of 2.84
- Lancor has Current ratio of 2.84
- Fusion Antibodies plc has Current ratio of 2.84
- 1&1 Drillisch AG has Current ratio of 2.84
- Automobile of Goa has Current ratio of 2.84